Sickle cell anaemia is a common inherited disorder with many chronic complications as well as acute presentations. Finally there are some novel treatments on the horizon. Dr Shivan Pancham discusses current management with Suzy.
Read MoreClinical use of granulocytes – Dr Suzy Morton
Granulocytes podcast with Helen and Suzy
Read MoreCurrent management of Essential Thrombocythaemia – Dr Hayder Hussein
Helen discusses Current management of Essential Thrombocythaemia – Dr Hayder Hussein
Read MoreDiagnosis and Treatment of Paroxysmal Nocturnal Haemoglobinuria – Dr Morag Griffin
PNH is a very rare disease but it is important for all haematologists to know when to test and what to do when a clone is detected
Read MoreAmyloidosis – Professor Guy Pratt
Amyloidosis – Professor Guy Pratt
Read MoreCharacteristics of blood group systems part 2: other blood group systems – Dr Tom Bullock
Characteristics of blood group systems part 2:
other blood group systems – Tom Bullock
Characteristics of blood group systems part 1: antibody testing and the Rh group – Dr Tom Bullock
Characteristics of blood group systems part 1: antibody testing and the Rh group with Tom Bullock
Read MoreAnticoagulation dilemmas – Dr Gill Lowe
Anticoagulation dilemmas with Gill Lowe
Read MorePlatelet aggregometry and inherited platelet disorders – Dr Gill Lowe
Familial ITP is very rare so if a FH exists, think about hereditary platelet disorders. Get historical plt counts and bleeding challenge history. Investigations: - FBC, film, coagulation, fibrinogen, von Willebrand screen, malaria screen, haematinics initially. - Platelet function testing – PFA 100 - uses whole blood. 2 cartridges with differing agonists. Read out is… Read More
CAR-T therapy – Dr Sridhar Chaganti
We are just at the start of what many are calling "the CAR-T cell revolution". But what are CAR-T cells, how are they made, who can receive them and what are the draw-backs? Dr Sridhar Chaganti talks to Suzy Morton about haematology's latest breakthrough. CAR-T = Chimeric Antigen Receptor T cells; T cells genetically modified… Read More